CAMP
CAMP
NASDAQ · Biotechnology

Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$3.85
-0.07 (-1.79%)
As of Sep 28, 10:15 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +211.9% upside
Low Target $8.14
Average Target $12.01
High Target $13.09
Current Price $3.85
Current
$3.85
Target
$12.01
$8.14 $12.01 avg $13.09
Scenario Analysis
Bear Case
$8.14
111.4%
Low target
Base Case
$12.01
+211.9%
Avg target
Bull Case
$13.09
+240.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$7.75
-50.3% from high
52-Week Low
$2.50
+54.0% from low
Target vs 52W High
$12.01
+55.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.4%